Scientific database and research platform CiteAb announced on Monday the launch of its CiteAb Explore Platform, comprising the Reagent Search Engine and new Image Search Engine.
Built on over a decade of AI-driven data collection combined with expert human curation, CiteAb's database contains 16 million research tools and their use in 40 million publications, covering antibodies, proteins, models, kits and more. As of 2026, instrument data is also included. This data underpins the Explore Platform, which helps researchers identify fit-for-purpose reagents, faster.
The new Image Search tool is designed to enable researchers to rapidly investigate peer-reviewed scientific images. Developed with input from the scientific community, it provides easy access to 850,000 cropped experimental images -- covering 610,000 proteins, 5,000 diseases, and 160,000 cell lines -- linked directly to publications and the reagents used.
Together, the research tools in CiteAb Explore are intended to help researchers cut time spent navigating fragmented data sources, reduce R&D waste, and achieve more reproducible results.
The CiteAb Explore platform is freely accessible to academics, with a paid subscription model for commercial users.
GSK's Jemperli wins FDA priority review for advanced rectal cancer
GSK secures first global approval for Hibsago in Japan
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
Rznomics joins Lilly Gateway Labs to accelerate RNA therapeutics
CureGene commences dosing in Phase I trial of CG-0416
Ipsen completes Kartos Therapeutics acquisition, strengthening late-stage oncology pipeline
Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV